Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1981-11

AUTHORS

V. S. Kalyanaraman, M. G. Sarngadharan, P. A. Bunn, J. D. Minna, R. C. Gallo

ABSTRACT

Although retroviruses (RNA tumour viruses) have been implicated in the causation of naturally occurring leukaemias and lymphomas of animals1, it is not yet clear whether they are involved in the human versions of these malignant diseases, particularly because of the difficulty in isolating viruses truly ascribable to human origin2,3. However, a novel type C retrovirus (called HTLVCR) has been isolated in our laboratory from T cells (fresh and in culture) from a lymph node biopsy of a patient (C.R.) with cutaneous T-cell lymphoma (mycosis fungoides)4 and a very similar virus (HTLVMB) from the peripheral blood T cells of another patient (M.B.) with cutaneous T-cell leukaemia (Sézary syndrome, see accompanying report5). The nucleic acid sequence6, the reverse transcriptase7 and the major internal structural protein (p24)8 of HTLVCR are not significantly related to any of the known retroviruses; nucleic acid sequences and p24 protein of HTLVMB have been recognized in fresh and cultured cells5. We now describe the results of a limited survey of the occurrence, in patients with T-cell malignancies (and among normal people), of antibodies against HTLVCR proteins. We find that antibodies against p24 are present in human sera (including those of patient C.R. and his wife), and that these are specifically directed at HTLVCR proteins and not at cell-specific determinants—in other words, the immunological reactions are not those reported in human sera9–11 against animal virus glycoproteins which, lacking virus specificity, are directed against the carbohydrate residues of the glycoprotein12,13. The antibodies against HTLV are thus the first evidence for a specific immune response in humans against a retrovirus. More... »

PAGES

271-273

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/294271a0

DOI

http://dx.doi.org/10.1038/294271a0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1026303985

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/6272126


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigen-Antibody Complex", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retroviridae", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sezary Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "T-Lymphocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Viral Proteins", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Cell Biology, Litton Bionetics Inc., 5516 Nicholson Lane, 20895, Kensington, Maryland, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Cell Biology, Litton Bionetics Inc., 5516 Nicholson Lane, 20895, Kensington, Maryland, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kalyanaraman", 
        "givenName": "V. S.", 
        "id": "sg:person.01174501451.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174501451.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Tumor Cell Biology, National Cancer Institute, 20205, Bethesda, Maryland, USA", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Laboratory of Tumor Cell Biology, National Cancer Institute, 20205, Bethesda, Maryland, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sarngadharan", 
        "givenName": "M. G.", 
        "id": "sg:person.016074327074.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016074327074.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Veteran's Administration Oncology Branch, National Cancer Institute, 20205, Bethesda, Maryland, USA", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Veteran's Administration Oncology Branch, National Cancer Institute, 20205, Bethesda, Maryland, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bunn", 
        "givenName": "P. A.", 
        "id": "sg:person.016651212042.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016651212042.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Veteran's Administration Oncology Branch, National Cancer Institute, 20205, Bethesda, Maryland, USA", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Veteran's Administration Oncology Branch, National Cancer Institute, 20205, Bethesda, Maryland, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Minna", 
        "givenName": "J. D.", 
        "id": "sg:person.013137077212.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013137077212.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Tumor Cell Biology, National Cancer Institute, 20205, Bethesda, Maryland, USA", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Laboratory of Tumor Cell Biology, National Cancer Institute, 20205, Bethesda, Maryland, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gallo", 
        "givenName": "R. C.", 
        "id": "sg:person.011012202251.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011012202251.12"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/294268a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011238845", 
          "https://doi.org/10.1038/294268a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1981-11", 
    "datePublishedReg": "1981-11-01", 
    "description": "Although retroviruses (RNA tumour viruses) have been implicated in the causation of naturally occurring leukaemias and lymphomas of animals1, it is not yet clear whether they are involved in the human versions of these malignant diseases, particularly because of the difficulty in isolating viruses truly ascribable to human origin2,3. However, a novel type C retrovirus (called HTLVCR) has been isolated in our laboratory from T cells (fresh and in culture) from a lymph node biopsy of a patient (C.R.) with cutaneous T-cell lymphoma (mycosis fungoides)4 and a very similar virus (HTLVMB) from the peripheral blood T cells of another patient (M.B.) with cutaneous T-cell leukaemia (S\u00e9zary syndrome, see accompanying report5). The nucleic acid sequence6, the reverse transcriptase7 and the major internal structural protein (p24)8 of HTLVCR are not significantly related to any of the known retroviruses; nucleic acid sequences and p24 protein of HTLVMB have been recognized in fresh and cultured cells5. We now describe the results of a limited survey of the occurrence, in patients with T-cell malignancies (and among normal people), of antibodies against HTLVCR proteins. We find that antibodies against p24 are present in human sera (including those of patient C.R. and his wife), and that these are specifically directed at HTLVCR proteins and not at cell-specific determinants\u2014in other words, the immunological reactions are not those reported in human sera9\u201311 against animal virus glycoproteins which, lacking virus specificity, are directed against the carbohydrate residues of the glycoprotein12,13. The antibodies against HTLV are thus the first evidence for a specific immune response in humans against a retrovirus.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/294271a0", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1018957", 
        "issn": [
          "0028-0836", 
          "1476-4687"
        ], 
        "name": "Nature", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5838", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "294"
      }
    ], 
    "keywords": [
      "T cells", 
      "human T-cell lymphoma virus", 
      "cutaneous T-cell lymphoma", 
      "peripheral blood T cells", 
      "T-cell lymphoma", 
      "blood T cells", 
      "specific immune response", 
      "internal structural proteins", 
      "human sera reactive", 
      "T-cell malignancies", 
      "T-cell leukemia", 
      "cell-specific determinants", 
      "major internal structural protein", 
      "malignant disease", 
      "immune response", 
      "type C retroviruses", 
      "sera reactive", 
      "virus specificity", 
      "immunological reactions", 
      "patients", 
      "antibodies", 
      "structural proteins", 
      "C retroviruses", 
      "lymphoma", 
      "leukemia", 
      "p24 protein", 
      "virus", 
      "similar viruses", 
      "virus glycoprotein", 
      "human serum", 
      "retroviruses", 
      "human version", 
      "first evidence", 
      "carbohydrate residues", 
      "cells", 
      "lymph", 
      "biopsy", 
      "humans", 
      "malignancy", 
      "HTLV", 
      "protein", 
      "disease", 
      "p24", 
      "mycosis", 
      "serum", 
      "nucleic acid sequences", 
      "glycoprotein", 
      "cells5", 
      "specificity", 
      "limited survey", 
      "response", 
      "evidence", 
      "determinants", 
      "causation", 
      "acid sequence", 
      "animals1", 
      "occurrence", 
      "survey", 
      "reactive", 
      "laboratory", 
      "difficulties", 
      "results", 
      "reaction", 
      "version", 
      "sequence", 
      "residues", 
      "words"
    ], 
    "name": "Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus", 
    "pagination": "271-273", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1026303985"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/294271a0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "6272126"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/294271a0", 
      "https://app.dimensions.ai/details/publication/pub.1026303985"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_178.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/294271a0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/294271a0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/294271a0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/294271a0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/294271a0'


 

This table displays all metadata directly associated to this object as RDF triples.

209 TRIPLES      21 PREDICATES      105 URIs      96 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/294271a0 schema:about N03af39c869f647c5af096653a5c4d75b
2 N15861ee3bb7844b59fb857ea593348fb
3 N196f3e911f7a4e25972b56187aa28734
4 N2e40b289c27241829224db10ad9ded22
5 N384cc1664ed54bf983320363cdb144f7
6 N3efc6cd7ed80467cba96744eccad7131
7 N5efa3f33dccf498cb4ab89bb80178ac2
8 N7e2fc5e3c29e4622a0493eb7d2d0eaa4
9 N94eb69dccd8c41b49391a4cc16db2c34
10 N95b87a635f5e42c5a04608b624150af2
11 Nd9a6c51c1e6344c9a56d3921c3d0d20e
12 anzsrc-for:11
13 anzsrc-for:1107
14 schema:author Ne2a1cafb65754da88e9c9da656113122
15 schema:citation sg:pub.10.1038/294268a0
16 schema:datePublished 1981-11
17 schema:datePublishedReg 1981-11-01
18 schema:description Although retroviruses (RNA tumour viruses) have been implicated in the causation of naturally occurring leukaemias and lymphomas of animals1, it is not yet clear whether they are involved in the human versions of these malignant diseases, particularly because of the difficulty in isolating viruses truly ascribable to human origin2,3. However, a novel type C retrovirus (called HTLVCR) has been isolated in our laboratory from T cells (fresh and in culture) from a lymph node biopsy of a patient (C.R.) with cutaneous T-cell lymphoma (mycosis fungoides)4 and a very similar virus (HTLVMB) from the peripheral blood T cells of another patient (M.B.) with cutaneous T-cell leukaemia (Sézary syndrome, see accompanying report5). The nucleic acid sequence6, the reverse transcriptase7 and the major internal structural protein (p24)8 of HTLVCR are not significantly related to any of the known retroviruses; nucleic acid sequences and p24 protein of HTLVMB have been recognized in fresh and cultured cells5. We now describe the results of a limited survey of the occurrence, in patients with T-cell malignancies (and among normal people), of antibodies against HTLVCR proteins. We find that antibodies against p24 are present in human sera (including those of patient C.R. and his wife), and that these are specifically directed at HTLVCR proteins and not at cell-specific determinants—in other words, the immunological reactions are not those reported in human sera9–11 against animal virus glycoproteins which, lacking virus specificity, are directed against the carbohydrate residues of the glycoprotein12,13. The antibodies against HTLV are thus the first evidence for a specific immune response in humans against a retrovirus.
19 schema:genre article
20 schema:isAccessibleForFree false
21 schema:isPartOf N512cdd8116e8477993cc28ef8d798b14
22 Nc6124eb222c54195baabae1dab76eabd
23 sg:journal.1018957
24 schema:keywords C retroviruses
25 HTLV
26 T cells
27 T-cell leukemia
28 T-cell lymphoma
29 T-cell malignancies
30 acid sequence
31 animals1
32 antibodies
33 biopsy
34 blood T cells
35 carbohydrate residues
36 causation
37 cell-specific determinants
38 cells
39 cells5
40 cutaneous T-cell lymphoma
41 determinants
42 difficulties
43 disease
44 evidence
45 first evidence
46 glycoprotein
47 human T-cell lymphoma virus
48 human sera reactive
49 human serum
50 human version
51 humans
52 immune response
53 immunological reactions
54 internal structural proteins
55 laboratory
56 leukemia
57 limited survey
58 lymph
59 lymphoma
60 major internal structural protein
61 malignancy
62 malignant disease
63 mycosis
64 nucleic acid sequences
65 occurrence
66 p24
67 p24 protein
68 patients
69 peripheral blood T cells
70 protein
71 reaction
72 reactive
73 residues
74 response
75 results
76 retroviruses
77 sequence
78 sera reactive
79 serum
80 similar viruses
81 specific immune response
82 specificity
83 structural proteins
84 survey
85 type C retroviruses
86 version
87 virus
88 virus glycoprotein
89 virus specificity
90 words
91 schema:name Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus
92 schema:pagination 271-273
93 schema:productId N70d3bec85cd6404c978323d6144588ec
94 Ne09da240473148a7acf2092c68d500e6
95 Ne96aade8422f4fcc93639c5d8d6605fe
96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026303985
97 https://doi.org/10.1038/294271a0
98 schema:sdDatePublished 2022-10-01T06:27
99 schema:sdLicense https://scigraph.springernature.com/explorer/license/
100 schema:sdPublisher Nf94750d556354c75a71ce93690601303
101 schema:url https://doi.org/10.1038/294271a0
102 sgo:license sg:explorer/license/
103 sgo:sdDataset articles
104 rdf:type schema:ScholarlyArticle
105 N03af39c869f647c5af096653a5c4d75b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Antibodies, Viral
107 rdf:type schema:DefinedTerm
108 N0d369cf00d7d41e0b805fcbdc808fa17 rdf:first sg:person.013137077212.11
109 rdf:rest N281f407bb37e4866a7573c3622bf3ad6
110 N15861ee3bb7844b59fb857ea593348fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Viral Proteins
112 rdf:type schema:DefinedTerm
113 N196f3e911f7a4e25972b56187aa28734 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Retroviridae
115 rdf:type schema:DefinedTerm
116 N281f407bb37e4866a7573c3622bf3ad6 rdf:first sg:person.011012202251.12
117 rdf:rest rdf:nil
118 N2e40b289c27241829224db10ad9ded22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Female
120 rdf:type schema:DefinedTerm
121 N384cc1664ed54bf983320363cdb144f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Humans
123 rdf:type schema:DefinedTerm
124 N3efc6cd7ed80467cba96744eccad7131 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Antigens, Viral
126 rdf:type schema:DefinedTerm
127 N512cdd8116e8477993cc28ef8d798b14 schema:volumeNumber 294
128 rdf:type schema:PublicationVolume
129 N5efa3f33dccf498cb4ab89bb80178ac2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name T-Lymphocytes
131 rdf:type schema:DefinedTerm
132 N66b3e16fb66a492ab115ed98259b13aa rdf:first sg:person.016074327074.81
133 rdf:rest Nb678f18f0ee24356970040ad42c7d5ee
134 N70d3bec85cd6404c978323d6144588ec schema:name doi
135 schema:value 10.1038/294271a0
136 rdf:type schema:PropertyValue
137 N7e2fc5e3c29e4622a0493eb7d2d0eaa4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Lymphoma
139 rdf:type schema:DefinedTerm
140 N94eb69dccd8c41b49391a4cc16db2c34 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Male
142 rdf:type schema:DefinedTerm
143 N95b87a635f5e42c5a04608b624150af2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Antigen-Antibody Complex
145 rdf:type schema:DefinedTerm
146 Nb678f18f0ee24356970040ad42c7d5ee rdf:first sg:person.016651212042.00
147 rdf:rest N0d369cf00d7d41e0b805fcbdc808fa17
148 Nc6124eb222c54195baabae1dab76eabd schema:issueNumber 5838
149 rdf:type schema:PublicationIssue
150 Nd9a6c51c1e6344c9a56d3921c3d0d20e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Sezary Syndrome
152 rdf:type schema:DefinedTerm
153 Ne09da240473148a7acf2092c68d500e6 schema:name pubmed_id
154 schema:value 6272126
155 rdf:type schema:PropertyValue
156 Ne2a1cafb65754da88e9c9da656113122 rdf:first sg:person.01174501451.32
157 rdf:rest N66b3e16fb66a492ab115ed98259b13aa
158 Ne96aade8422f4fcc93639c5d8d6605fe schema:name dimensions_id
159 schema:value pub.1026303985
160 rdf:type schema:PropertyValue
161 Nf94750d556354c75a71ce93690601303 schema:name Springer Nature - SN SciGraph project
162 rdf:type schema:Organization
163 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
164 schema:name Medical and Health Sciences
165 rdf:type schema:DefinedTerm
166 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
167 schema:name Immunology
168 rdf:type schema:DefinedTerm
169 sg:journal.1018957 schema:issn 0028-0836
170 1476-4687
171 schema:name Nature
172 schema:publisher Springer Nature
173 rdf:type schema:Periodical
174 sg:person.011012202251.12 schema:affiliation grid-institutes:grid.48336.3a
175 schema:familyName Gallo
176 schema:givenName R. C.
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011012202251.12
178 rdf:type schema:Person
179 sg:person.01174501451.32 schema:affiliation grid-institutes:None
180 schema:familyName Kalyanaraman
181 schema:givenName V. S.
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174501451.32
183 rdf:type schema:Person
184 sg:person.013137077212.11 schema:affiliation grid-institutes:grid.48336.3a
185 schema:familyName Minna
186 schema:givenName J. D.
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013137077212.11
188 rdf:type schema:Person
189 sg:person.016074327074.81 schema:affiliation grid-institutes:grid.48336.3a
190 schema:familyName Sarngadharan
191 schema:givenName M. G.
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016074327074.81
193 rdf:type schema:Person
194 sg:person.016651212042.00 schema:affiliation grid-institutes:grid.48336.3a
195 schema:familyName Bunn
196 schema:givenName P. A.
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016651212042.00
198 rdf:type schema:Person
199 sg:pub.10.1038/294268a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011238845
200 https://doi.org/10.1038/294268a0
201 rdf:type schema:CreativeWork
202 grid-institutes:None schema:alternateName Department of Cell Biology, Litton Bionetics Inc., 5516 Nicholson Lane, 20895, Kensington, Maryland, USA
203 schema:name Department of Cell Biology, Litton Bionetics Inc., 5516 Nicholson Lane, 20895, Kensington, Maryland, USA
204 rdf:type schema:Organization
205 grid-institutes:grid.48336.3a schema:alternateName Laboratory of Tumor Cell Biology, National Cancer Institute, 20205, Bethesda, Maryland, USA
206 Veteran's Administration Oncology Branch, National Cancer Institute, 20205, Bethesda, Maryland, USA
207 schema:name Laboratory of Tumor Cell Biology, National Cancer Institute, 20205, Bethesda, Maryland, USA
208 Veteran's Administration Oncology Branch, National Cancer Institute, 20205, Bethesda, Maryland, USA
209 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...